Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Deflector-type micro-capsule suspension type fluidized bed bioreactor for artificial liver

A bioreactor and flow-through microtechnology, which is applied in the field of biomedicine, can solve the problems of increased microcapsule fragmentation rate, limited fluid shear force, and inability to guarantee the biological safety of the treatment process, so as to improve purification efficiency and purification efficiency. , to ensure the effect of contact

Inactive Publication Date: 2013-06-26
ZHEJIANG UNIV
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In response to these shortcomings, our laboratory has developed a microcapsule suspension fluidized bed bioreactor for artificial liver (patent number: ZL 200820167026.5) and a supporting dual-chamber liquid storage tank for bioartificial liver support system (patent number: ZL 200710070279.0), and built a new type of bioartificial liver system based on it. Animal experiments showed that the system has good curative effect, but also found that it still needs to be perfected and improved: 1. The reactor needs more Only a high liquid flow rate can make the microencapsulated hepatocytes fully suspended and fluidized, but the fluid shear force that the microcapsules that wrap the cells can withstand is limited; Flow dead space, some microencapsulated hepatocytes cannot fully contact the fluidized liquid; 3. The microcapsule suspension type fluidized bed bioreactor for artificial liver (patent number: ZL 200820167026.5) has a small liquid inlet, and increasing the flow rate can cause the inlet The local liquid flow rate is too fast, and the fluid shear force on the local microcapsules is too large, which leads to an increase in the microcapsule breakage rate
4. The dissolved oxygen content must be detected at the inlet and outlet of the reactor, and the previous contact detection method cannot guarantee the biological safety during the treatment process

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Deflector-type micro-capsule suspension type fluidized bed bioreactor for artificial liver
  • Deflector-type micro-capsule suspension type fluidized bed bioreactor for artificial liver

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0023] Such as figure 2 As shown, the flow-guiding microcapsule suspension fluidized bed bioreactor for the artificial liver of the present invention is the core component of the biological cycle 33 in the biological artificial liver system. Now with figure 2 Taking the simple biological artificial liver treatment mode as an example, the specific implementation scheme of the present invention is introduced.

[0024] Treatment preparation, open the valve 5, pour the microcapsule-coated hepatocytes into the cylindrical inner cavity of the main body part 16 of the reactor through the sampling and microcapsule perfusion port 6, close the perfusion port valve after the microcapsule perfusion is completed, and inject the hepatic cells from the liquid inlet 11 Slowly preflush the prepared circulating buffer. Remove all air bubbles from the circulation lines and check the system for tightness. At this time, since the pore size of the inlet filter screen is smaller than the di...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Volumeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a deflector-type micro-capsule suspension type fluidized bed bioreactor for an artificial liver. The deflector-type micro-capsule suspension type fluidized bed bioreactor for the artificial liver comprises an end cover part, a main body part and a base part, wherein the base part comprises an inlet buffer tank, a fixed turbine guide vane, and an inlet filter net arranged at the joint surface of the base part and a subject part; the main body part comprises a cylindrical containing cavity, a sampling and micro-capsule pouring lip and a valve; the sampling and micro-capsule pouring lip and the valve are arranged in a housing of the main body part; and the top cover part comprises an outlet buffer tank, and an outlet filter net arranged at the joint surface of the subject part and the top cover part. By adopting the sealed structure and a multi-opening design, the microencapsulated hepatocyte can be conveniently sampled and added; and meanwhile, the possibility of pollution in an operation process is reduced. The turbine guide vane of the base part can disperse large local flow speed at the inlet; micro-capsule damage is reduced; and the blood purification efficiency is improved. By adopting the deflector-type micro-capsule suspension type fluidized bed bioreactor for the artificial liver, the contact efficiency of the cultivated cell in the bioreactor and perfusate can be improved; meanwhile, the cyclic purification efficiency of the biological part in an artificial liver system is improved; and clinic application is facilitated.

Description

technical field [0001] The invention belongs to the technical field of biomedicine and relates to a medical device, which is a core device of a specific biological artificial liver or a hybrid artificial liver. Background technique [0002] The bioreactor is the core device of the bioartificial liver system or hybrid artificial liver system. Its main function is to have sufficient capacity and efficiency to provide patient plasma and exogenous liver cells for material exchange, and at the same time, it needs to have the ability of immune isolation . The type of bioreactor that has been researched hotspots in the past and has entered clinical trials is mainly a hollow fiber reactor, but it has disadvantages such as uneven cell distribution, low cell adhesion rate and activity, and semipermeable membrane blockage. At the same time, it has been found that microencapsulated hepatocytes have potential value for bioartificial livers—the shell of the microcapsules that wrap th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61M1/14
Inventor 李兰娟俞亮喻成波
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products